Best TradingView Alternative in 2026 –
An Honest Comparison
March 29, 2026 · 8 min read · CompoundPulse Team
TradingView is still one of the best charting platforms available. The issue isn't the product — it's that many traders end up paying for charting and then adding separate tools for screening, backtesting, or research workflows that TradingView doesn't cover out of the box.
If you rely on Pine Script or TradingView's social layer, staying there makes sense. If you want charting, screening, and backtesting that works without learning a scripting language — CompoundPulse is built for that workflow.
Bottom line up front: This is not a "TradingView is bad" article. It's a workflow comparison. TradingView can do most of these jobs. The question is whether the extra friction — Pine Script for backtesting, additional data subscriptions for real-time feeds, separate tools for some research workflows — is worth the cost for the way you actually trade.
What TradingView Charges You For
Here's the TradingView pricing breakdown as of 2026. Note that some exchanges charge additional real-time data fees on top of the subscription price — so your actual cost may be higher depending on what markets you trade.
| Plan | Price | Key Notes |
|---|---|---|
| Free | $0 | 2 indicators per chart, 3 active price alerts, data timing varies by feed |
| Essential | $12.95/mo (billed annually) | 5 indicators, 20 price alerts, 30-day trial |
| Plus | $29.95/mo (billed annually) | 10 indicators, 100 price alerts, 30-day trial |
| Premium | $59.95/mo (billed annually) | 25 indicators per chart, 400 price alerts, 30-day trial — exchange data add-ons may apply separately |
Feature-for-Feature: TradingView Plus vs CompoundPulse Pro
| Feature | TradingView Plus ($29.95) | CompoundPulse Pro |
|---|---|---|
| Technical indicators | 10 per chart | 75+ per chart, all enabled |
| Chart types | Candle, Bar, Line, Area, HA | Same 5 types |
| Timeframes | 1m → Monthly | 1m → 5Y |
| Drawing tools | Full suite | Full suite + saved to cloud |
| Symbol comparison overlay | Yes | Yes — type "vs…" on any chart |
| Chart replay (bar-by-bar) | Yes (Pro+ only) | Yes — all plans |
| Multi-chart layout | Up to 4 panes | Up to 4 panes, each with own ticker |
| Stock screener | Many filters; separate from main chart workflow | Finviz-style, many filters, opens directly in chart |
| Backtesting | Strategy Tester — strongest with Pine Script | Built-in, zero code required |
| Options chain data | Basic | Full options page |
| Insider activity | Available via News Flow / corporate tools | Dedicated tracker — every Form 4 filing |
| Earnings calendar | Yes | Yes |
| Economic calendar | Yes | Yes |
| Market heatmaps | Yes | Yes |
| Crypto / Forex / Futures | Yes | Yes — dedicated pages per asset class |
| Asset correlation | Available via official indicator | Built-in matrix — stocks, ETFs, crypto, forex |
| Price alerts | 20 alerts | Unlimited — email + browser push |
| Paper trading | Yes (Premium only) | Yes |
| Portfolio tracker | Basic | Yes |
| Free trial | 30-day trial on paid plans | 7-day trial, no credit card required |
| Market data fees | Some exchanges require add-on subscriptions | Check pricing page for current data terms |
Where the Workflow Difference Actually Shows Up
TradingView can do most of these jobs. What the table above doesn't fully capture is how much friction sits between you and the result in each case. Here's where that gap is most noticeable in practice:
1. Backtesting Pushes You Toward Pine Script
TradingView's Strategy Tester is genuinely capable — you can backtest built-in strategies and community scripts without writing a line of code. But the moment you want to test your own rules with custom logic, you're writing Pine Script. For most retail traders, that's where the workflow stops. The learning curve is real, and the time cost is real.
CompoundPulse's backtester is built for traders who don't want to write code at all. Pick a ticker, pick a strategy, hit run. You get a full equity curve, win rate, max drawdown, Sharpe ratio, and comparison to buy-and-hold — in about 10 seconds.
2. Insider Activity Lives in a Different Part of the Platform
TradingView surfaces some corporate activity through its News Flow, but it's not a dedicated insider trading tracker. Finding Form 4 filings — who bought, who sold, how many shares, at what price — requires leaving the chart and hunting for the data elsewhere.
CompoundPulse keeps a dedicated insider tracker alongside every chart. When the CFO of a company you're watching quietly buys $1.5M of their own stock, that shows up in your research workflow without a separate tab.
3. The Screener Lives in a Separate Workflow
TradingView's screener is capable — a wide range of filter fields across multiple screener types. But it lives separately from the charting environment. You screen for a setup, then manually open the chart in another view. For traders who move between screener and chart dozens of times a session, that friction compounds.
On CompoundPulse, a screener result opens directly into the chart with your indicator layout already applied. No tab switching, no re-applying settings.
4. Correlation Requires a Separate Indicator Setup
TradingView has a correlation heatmap available as an official indicator. It works, but it requires adding it to a chart and configuring it manually each time. CompoundPulse has a standalone correlation matrix page — add any mix of tickers and see the full correlation grid immediately, without indicator setup.
Where TradingView Still Wins
Being honest matters. Here's where TradingView is genuinely better:
- Pine Script — If you've already written scripts, indicators, or strategies in Pine Script, they live in TradingView and nowhere else. The ecosystem is massive.
- Social features — TradingView has a real community: published chart ideas, trader profiles, comments, followers. If you publish your analysis publicly, there's no equivalent elsewhere.
- Broker integration — Some brokers connect directly to TradingView for one-click trading. CompoundPulse has paper trading but not live broker integration yet.
- Mobile app — TradingView's mobile app is excellent. CompoundPulse is mobile-responsive in browser but doesn't have a dedicated app yet.
Our honest take: If you're a heavy Pine Script user with hundreds of saved scripts, switching costs are real. For everyone else — if you're paying $30/month for charts and a mediocre screener — you should at least try the free trial and compare side by side.
Who Should Switch
- You're paying for TradingView Plus/Premium and you never open the Pine Script editor
- You want backtesting without learning to code
- You use Finviz separately and want to consolidate into one platform
- You trade based on insider activity and want it next to your charts
- You run a portfolio and care about correlation
- You want unlimited price alerts with email delivery (TradingView caps alerts and charges more for server-side)
Who Should Stay on TradingView
- You have a library of Pine Script strategies you rely on
- You publish chart ideas and have a following on TradingView
- You use a broker with direct TradingView integration
- You need Level 2 order book data
Most traders don't lose because they're bad at this.
They lose because they keep entering without seeing the full picture — the trend, the pressure, the confirmation — and by the time they feel it, they're already trapped. The traders who actually compound aren't smarter. They just see it first. That's what CompoundPulse is built for.
Try CompoundPulse Free — No Credit CardRelated: Best Free Stock Screener · Top 10 Technical Indicators · How to Backtest a Strategy